ALNYLAM PHARMACEUTICALS INC filings

SEC filings by ALNYLAM PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2010-01-29BlackRock Inc.ALNYLAM PHARMACEUTICALS, INC.2,362,6375.6%EDGAR
SC 13G/A2009-02-17FMR LLCALNYLAM PHARMACEUTICALS, INC.6,211,96315.0%EDGAR
SC 13G/A2009-02-17Aletheia Research & Management, Inc.ALNYLAM PHARMACEUTICALS, INC.2,791,1916.7%EDGAR
SC 13G/A2009-02-09NOVARTIS AGALNYLAM PHARMACEUTICALS, INC.5,481,75313.2%EDGAR
SC 13G2009-02-05BARCLAYS GLOBAL INVESTORS NA /CA/ALNYLAM PHARMACEUTICALS, INC.875,1632.1%EDGAR
SC 13G/A2008-02-14FMR LLCALNYLAM PHARMACEUTICALS, INC.6,104,98215.0%EDGAR
SC 13G/A2008-02-14Aletheia Research & Management, Inc.ALNYLAM PHARMACEUTICALS, INC.2,748,4696.8%EDGAR
SC 13G/A2008-02-13Abingworth Management LTDALNYLAM PHARMACEUTICALS, INC.--EDGAR
SC 13G2007-06-08Aletheia Research & Management, Inc.ALNYLAM PHARMACEUTICALS, INC.2,443,9966.5%EDGAR
SC 13D/A2007-02-14CHP II LPALNYLAM PHARMACEUTICALS, INC.00.0%EDGAR
SC 13G/A2007-02-14FMR CORPALNYLAM PHARMACEUTICALS, INC.5,549,61015.0%EDGAR
SC 13G/A2007-02-14ARCH VENTURE FUND V LPALNYLAM PHARMACEUTICALS, INC.--EDGAR
SC 13G/A2007-02-13Abingworth Management LTDALNYLAM PHARMACEUTICALS, INC.2,040,0006.3%EDGAR
SC 13G/A2007-02-12ATLAS VENTURE FUND V LPALNYLAM PHARMACEUTICALS, INC.--EDGAR
SC 13G/A2006-02-23POLARIS VENTURE PARTNERS III LPALNYLAM PHARMACEUTICALS, INC.365,8521.4%EDGAR
SC 13D/A2006-02-15CHP II LPALNYLAM PHARMACEUTICALS, INC.1,391,8706.6%EDGAR
SC 13G/A2006-02-14FMR CORPALNYLAM PHARMACEUTICALS, INC.3,461,98713.0%EDGAR
SC 13G/A2006-02-14POLARIS VENTURE PARTNERS III LPALNYLAM PHARMACEUTICALS, INC.1,938,5327.3%EDGAR
SC 13G/A2006-02-14ARCH VENTURE FUND V LPALNYLAM PHARMACEUTICALS, INC.1,532,6975.8%EDGAR
SC 13G/A2006-02-13Abingworth Management LTDALNYLAM PHARMACEUTICALS, INC.2,150,00010.3%EDGAR